Intravenous Immunoglobulin Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Intravenous Immunoglobulin Market was valued at approximately USD 10,183.35 million in 2020 and is expected to witness a revenue of USD 15,344.93 million by 2027, with a CAGR of 7% over the forecast period (2021-2027).

The term “immunoglobulin” refers to the degradation of plasma-containing antibodies. IVIg is a blood product given intravenously. Contains polyvalent IgG antibodies derived from the plasma of more than thousands of blood donors. Individuals who cannot produce adequate amounts of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia, and other forms of hypogammaglobulinemia, benefit from IVIg to maintain adequate levels of antibodies in the body. Do it.

Market Segments

By Application

• Hypogammaglobulinemia
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Immunodeficiency Disease
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• Idiopathic Thrombocytopenic Purpura (ITP)
• Inflammatory Myopathies
• Specific Antibody Deficiency
• Guillain–Barré Syndrome
• Others

By Type

• IgG
• IgA
• IgM
• IgE
• IgD

Key Players

Some of the key players operating in IVIg market are Baxter International Inc., Beijing Tiantan Biological Products Co., Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Guizhou Taibang Biological Products Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., Octapharma AG, Grifols, S.A, Hualan Biological Engineering Inc., OMRIX Biopharmaceuticals Ltd., and Kedrion S.p.A.

Scope of the Report

The research study analyzes the global Intravenous Immunoglobulin industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Intravenous Immunoglobulin Market Report

1. What was the Intravenous Immunoglobulin Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Intravenous Immunoglobulin Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Intravenous Immunoglobulin Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.